Neuroscience and Behavioral Physiology

, Volume 38, Issue 1, pp 99–102

Ca2+/calmodulin-dependent protein kinase II — a target for sodium valproate?

  • T. A. Savina
  • O. A. Balashova
  • T. G. Shchipakina


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    A. F. Semiokhina, I. B. Fedotova, and L. M. Kuznetsova, “Krushinskii-Molodkina rats as a model for studies of pathological states and methods for regulating them,” Lab. Zhivot., 3, No. 4, 202–210 (1993).Google Scholar
  2. 2.
    T. A. Savina, I. B. Fedotova, I. I. Poletaeva, A. F. Semiokhina, and T. G. Shchipakina, “Long-term effects of early postnatal administration of the epiphyseal hormone melatonin on audiogenic convulsions in Krushinskii-Molodkina rats,” Zh. Vyssh. Nerv. Deyat., 55, No. 1, 107–115 (2005).Google Scholar
  3. 3.
    I. B. Fedotova, A. F. Semiokhina, D. A. Fless, and G. V. Arkhipova, “Effects of diphenin, valproate, and pentobarbital on the development of epileptiform convulsive seizures in Krushinskii-Molodkina rats,” Zh. Vyssh. Nerv. Deyat., 46, No. 6, 1104–1108 (1996).Google Scholar
  4. 4.
    T. A. Chulanova, S. N. Echikov, V. B. Sadovnikov, and T. G. Shchipakina, “Functional characteristics of MAP2 in mice of the inbred strain DBA/2J as a component of the genetic predisposition to convulsions,” Byull. Éksperim. Biol. Med., 11, 522–526 (2001).Google Scholar
  5. 5.
    G. G. Shan’ko, E. N. Ivashina, and N. M. Charukhina, “Comparative assessment of the efficacies of various valproates in epilepsy in children,” Med. Novosti, 9, 57–61 (2001).Google Scholar
  6. 6.
    A. Barria, D. Muller, and V. Derkach, “Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation,” Science, 276, No. 5321, 2042–2045 (1997).PubMedCrossRefGoogle Scholar
  7. 7.
    S. B. Churn, L. D. Kochan, and R. J. DeLorenzo, “Chronic inhibition of Ca2+/calmodulin kinase II activity in the pilocarpine model of epilepsy,” Brain Res., 875, 66–77 (2000).PubMedCrossRefGoogle Scholar
  8. 8.
    S. B. Churn, A. Rana, K. Lee, J. T. Parsons, A. De Blas, and R. J. DeLorenzo, “Calcium/calmodulin-dependent kinase II phosphorylation of the GABAA receptor alpha1 subunit modulates benzodiazepine binding,” J. Neurochem., 82, No. 5, 1065–1076 (2002).PubMedCrossRefGoogle Scholar
  9. 9.
    C. L. Faingold, “Role of GABA abnormalities in the inferior colliculus pathophysiology — audiogenic seizures,” Hear. Res., 168, No. 1–2, 223–237 (2002).PubMedCrossRefGoogle Scholar
  10. 10.
    A. Hudmon and H. Schulman, “Neuronal Ca2+/calmodulin-dependent protein kinase II: the role of structure and autoregulation in cellular function,” Ann. Rev. Biochem., 71, 473–510 (2002).PubMedCrossRefGoogle Scholar
  11. 11.
    C. U. Johanessen, “Mechanisms of action of valproate: a commentatory,” Neurochem. Int., 37, No. 2–3, 103–110 (2000).CrossRefGoogle Scholar
  12. 12.
    M. Kano, M. Kano, K. Fukunaga, and A. Konnerth, “Ca2+-induced rebound potentiation of γ-aminobutyric acid-mediated currents requires activation of Ca2+/calmodulin-dependent kinase II,” Proc. Natl. Acad. Sci. USA, 93, No. 23, 13351–133Google Scholar
  13. 13.
    J. E. Kralic, E. R. Korpi, T. K. O’Buckley, G. E. Homanics, and A. L. Morrow, “Molecular and pharmacological characterization of GABA(A) receptor alphal subunit knockout mice,” J. Pharmacol. Exptl. Ther., 302, No. 3, 1037–1045 (2002).CrossRefGoogle Scholar
  14. 14.
    S. V. Rakhilin, P. A. Olsen, A. Nishi, et al., “A network of control mediated by regulator of calcium/calmodulin-dependent signaling,” Science, 306, No. 5696, 698–701 (2004).PubMedCrossRefGoogle Scholar
  15. 15.
    K. C. Ross and J. R. Coleman, “Developmental and genetic audiogenic seizure models: behavior and biological substrates,” Neurosci. Biobehav. Rev., 24, 639–653 (2000).PubMedCrossRefGoogle Scholar
  16. 16.
    S. Sessoms-Sikes, Y. Honse, D. M. Lovinger, and R. J. Colbran, “CaMKIIalpha enhances the desensitization of NR2B-containing NMDA receptors by an autophosphorylation-dependent mechanism,” Mol. Cell. Neurosci., 29, No. 1, 139–147 (2005).PubMedCrossRefGoogle Scholar
  17. 17.
    T. R. Soderling, “CaM-kinases: modulators of synaptic plasticity,” Curr. Opin. Neurobiol., 10, No. 3, 375–380 (2000).PubMedCrossRefGoogle Scholar
  18. 18.
    S. N. Yechikov, E. D. Morenkov, T. A. Chulanova, O. V. Godukhin, and T. G. Shchipakina, “Involvement of c AMP-and Ca2+/calmodulin-dependent neuronal protein phosphorylation in mechanisms underlying genetic predisposition to audiogenic seizures in rats,” Epilepsy Res., 46, 15–25 (2001).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2008

Authors and Affiliations

  • T. A. Savina
    • 1
  • O. A. Balashova
    • 1
  • T. G. Shchipakina
    • 1
  1. 1.Institute of Theoretical and Experimental BiophysicsRussian Academy of SciencesMoscow Region

Personalised recommendations